Based on this, we further certificated Galectin-1 (LGALS1, the key gene in LFMRS model) plays a key role in lipid metabolism reprogramming, immunosuppressive effect, AML progress in vitro and in vivo. The gene discussed is LGALS1; the disease is acute myeloid leukemia.